K
Kynam Capital Management, LP Portfolio Analytics
Investment Analysis & Holdings Breakdown
Comprehensive portfolio analytics for Kynam Capital Management, LP with $1.3B in long positions as of Q3 2025, 93% allocated to Healthcare, and 73% concentrated in top 10 positions.
- Portfolio Value
- $1.3B
- Top 10 Concentration
- 73%
- Top Sector
- Healthcare (93%)
- US Exposure
- 93%
- Market Cap Focus
- Small Cap
- Countries
- 4
Composition Analysis
Portfolio breakdown by sector, industry, and market capitalization
Sector Allocation
Industry Breakdown
No industry data available
Market Cap Distribution
Portfolio Concentration
Geographic Exposure
Portfolio breakdown by country of incorporation
Domestic (US)
International
Countries
Largest Int'l Market
Holding Behavior
Investment patterns and position management analysis
Portfolio Stability & Commitment
- Persistence Rate
- 54.29%
- Persistent Holdings Weight
- 83.34%
- Persistent Positions
- 19
Position Sizing & Influence
Current Quarter
- Avg. New Position
- 1.47%
- Avg. Position Weight
- 2.86%
- Largest Position
Celldex Therapeutics, IncCLDX - 11.75%- Largest Ownership Stake
Syndax Pharmaceuticals, Inc.SNDX - 9.89%- Avg. Ownership Stake
- 4.98%
- Ownership Stake >5%
- 7
- Ownership Stake >1%
- 27
Historical (Since Q4 2021)
- Avg. New Position
- 2.89%
- Avg. Ownership Stake
- 3.81%
- Largest Position
Natera, Inc. Common StockNTRA - 23.07% (Q3 2022)- Largest Ownership Stake
2seventy bio, Inc. Common StockTSVT - 11.80% (Q3 2023)
Portfolio Turnover
Current Quarter
- Turnover Ratio
- 7.2%
- Value Traded
- $96.78M
- Positions Added
- 3
- Positions Exited
- 1
Historical (Since Q4 2021)
- Avg. Turnover Ratio
- 19.4%
- Avg. Positions Added
- 5
- Avg. Positions Exited
- 3
- Highest Turnover
- 50.0%Q4 2021
- Lowest Turnover
- 7.2%Q3 2025